Top 10 Largest Microfluidics Companies in 2025

Microfluidics is a technology that enables scientists and engineers to control very small amounts of liquid. These fluids are controlled through channels that are often smaller than human hair. Microfluidic systems are usually small and combine knowledge from various scientific disciplines.

Microfluidics is transforming various sectors globally. It’s making medical testing faster and more accurate. It is also accelerating drug development and improving food safety. The rapid growth of the field has led several companies to introduce innovative solutions. In this article, we explain to you the fundamentals of microfluidics. We’ll also cover the top microfluidics market companies offering innovative solutions.

Microfluidics: Overview

Microfluidics is the science and technology of handling minimal amounts of liquids through tiny channels. The behavior of liquids at this scale is different from what we see in everyday life. As a result, scientists can control them with greater precision.

Engineers leverage this principle to design microfluidic devices. These devices, also referred to as “labs-on-a-chip,” can perform the same functions as a full laboratory. However, these functions are processed much faster and more efficiently. Additionally, their lower use of samples and reagents makes experiments cheaper and less wasteful. The speed, accuracy, and compact size of microfluidic systems make them applicable in several areas.

What Are Key Market Stats?

Our analysis reveals that the microfluidics market is expected to witness sustained growth in the coming years. The market for microfluidics is expected to account for a CAGR of 11.1% during the projection period. It is expected to grow to USD 86.23 billion by 2032.

What Are the Key Features of Microfluidic Systems?

Miniaturization: Microfluidics enables the shrinkage of entire laboratory functions onto chip-sized devices.

Precision Control: It provides highly accurate regulation of fluid flow and mixing. This is essential for reliable results.

High Throughput: Microfluidics improves efficiency by enabling multiple experiments or tests to be run simultaneously.

Low Sample and Reagent Consumption: Microfluidics requires only small amounts of sample, which reduces costs and waste.

Rapid Analysis: Processes that normally take hours or days can be completed much faster. Rapid sample analysis supports faster diagnostics and research.

Where Is Microfluidics Used?

Drug Development: Microfluidics helps pharmaceutical companies test drugs faster and more efficiently. High-throughput screening and precise dosing, supported by microfluidics, help key players in the drug discovery services market speed up their offerings. Additionally, it lowers the need for animal testing.

Healthcare and Diagnostics: The microfluidics market is transforming medical testing. It is making it possible to detect diseases like COVID-19, HIV, and cancer quickly at the point of care. Early diagnosis improves patient outcomes and reduces healthcare costs.

Food and Beverages Industry: Microfluidics helps improve safety and innovation in food production. It allows the creation of new textures and the identification of pathogens. For example, microfluidic emulsification is used to produce low-fat spreads and other healthier products.

Environmental Monitoring: Small and affordable microfluidic sensors can track pollutants, toxins, and pathogens in air and water. Their ability to provide real-time data makes them highly valuable for protecting the environment and public health.

Who Offers Microfluidics Solutions?

Danaher Corporation (Cepheid & Sciex)

Headquarters: Washington, D.C., USA

Key Product: GeneXpert System, a widely used microfluidic-based PCR testing platform for infectious diseases.

Established: 1984

Danaher Corporation: Danaher is a U.S.-based global conglomerate. It is known for its wide range of medical, industrial, and commercial products. Danaher’s portfolio includes diagnostic systems, testing instruments, life science research tools, and professional microscopes. Its leading subsidiaries, including Cepheid and Sciex, play a crucial role in microfluidics-driven diagnostics and analytical instruments.

Fluidigm Corporation (Now Standard BioTools)

Headquarters: San Francisco, California, USA

Key Product: Biomark HD System, a high-throughput PCR and sequencing platform using microfluidics.

Established: 1999

Standard BioTools is a U.S.-based life science company specializing in advanced analytical technologies. It is known for its mass cytometry systems for flow cytometry and tissue imaging. The company also offers related assays and reagents. Standard BioTools’ solutions support advanced research in cancer, immunology, and immunotherapy.

Bio-Rad Laboratories

Headquarters: Hercules, California, USA

Key Product: QX200 Droplet Digital PCR System. The system offers ultra-sensitive nucleic acid quantification.

Established: 1952

Bio-Rad is a key player in droplet-based microfluidics. The company is known for its droplet digital PCR (ddPCR) technology. The ability of the ddPCR technology to enable absolute quantification of DNA and RNA makes it highly valuable in cancer research and infectious disease detection. The company also integrates microfluidics into products such as the Experion system, enabling fast, automated analysis of proteins and nucleic acids.

PerkinElmer (Revvity)

Headquarters: Shelton, Connecticut, USA

Key Product: AlphaLISA Assay Technology. Uses microfluidics for biomarker detection.

Established: 1937

PerkinElmer is a U.S.-based global corporation. It was formerly known as Perkin-Elmer. The company specializes in analytical instruments, genetic testing solutions, diagnostic tools, and medical imaging components. Its broad portfolio of technologies and services spans detection, imaging, informatics, and laboratory services.

Illumina, Inc.

Headquarters: San Diego, California, USA

Key Product: MiSeqDx System. A compact sequencing platform for clinical applications.

Established: 1998

Illumina is a global leader in next-generation sequencing (NGS) technologies. The company has incorporated microfluidics to boost the speed and accuracy of its platforms. Its proprietary digital microfluidics technology, based on electrowetting, enables precise manipulation of tiny droplets within sealed cartridges. These innovations play a vital role in advancing genetic research and personalized medicine.

Other key microfluidics market companies are:

Roche: The firm utilizes microfluidic technologies in its diagnostics division. It implements the technology with its instruments as well as its point-of-care (POC) testing platforms.

Agilent Technologies, Inc.: Agilent Technologies provides microfluidics technologies in its automated electrophoresis systems and high-performance liquid chromatography (HPLC) chip technology.

Abbott Laboratories: The firm utilizes microfluidics in portable POC diagnostic systems such as the i-STAT System and the Afinion System.

Thermo Fisher Scientific: The company provides microfluidics solutions in its digital PCR (dPCR) instruments and recent acquisitions.

BioMérieux: BioMérieux uses microfluidics extensively in its infectious disease diagnostics, particularly its BIOFIRE product line.

What Are Key Market Trends?

Integration with Artificial Intelligence (AI): Integrating microfluidics with solutions from the AI in healthcare market is opening new possibilities for research and healthcare. The ability of AI to optimize device design and analyze complex data results in faster diagnostics and more effective therapies.

Smart Wearable Microfluidics: This innovation brings microfluidics to flexible, wearable devices that analyze biofluids. It enables continuous and real-time monitoring of biomarkers and overall health conditions.

3D-Printed Microfluidic Devices: 3D printing enables the creation of customizable, low-cost microfluidic systems. These devices support rapid fabrication of complex channels. They are widely used in cell culture, chemical testing, and biomedical research.

Conclusion

The microfluidics market is changing modern science. It is enabling breakthroughs in diagnostics, drug discovery, genomics, and environmental monitoring. By enabling precise control of tiny fluid volumes, it is making healthcare more accessible and research more efficient. The integration of advanced technologies is set to expand its potential even further in the coming years.